Moreover, Keremu et al. reported that EVs from BMSCs transported microRNA-206 into osteosarcoma cells and targeted NRSN2 to block the ERK1/2-Bcl-xL signaling pathway, thus inhibiting OS progression [96]. This evidence concerns the gene NRSN2 and osteosarcoma.